Evidence map›Paper›PMID 29187532›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.

Junki Hirano, Toru Okamoto, Yukari Sugiyama, Tatsuya Suzuki, Shinji Kusakabe, Makoto Tokunaga, Takasuke Fukuhara, Miwa Sasai, Takahiro Tougan, Yasue Matsunaga and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Structural insights into human signal peptide peptidase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Review
  4. Article
  5. Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Review
  7. Physiological functions of SPP/SPPL intramembrane proteases.Cellular and molecular life sciences : CMLS · 2020
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Junki HiranoDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Toru OkamotoDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; toru@biken.osaka-u.ac.jp matsuura@biken.osaka-u.ac.jp.
Yukari SugiyamaDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Tatsuya SuzukiDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Shinji KusakabeDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Makoto TokunagaDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Takasuke FukuharaDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Miwa SasaiDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Takahiro TouganDepartment of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Yasue MatsunagaPlanning and Promotion Office for University-Industry Collaboration, Osaka University, Osaka 565-0871, Japan.
Kazuo YamashitaKOTAI Biotechnologies, Inc., Osaka, Japan.
Yusuke SakaiDepartment of Veterinary Pathology, Yamaguchi University, Yamaguchi 753-0841, Japan.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Toshihiro HoriiDepartment of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Daron M StandleyDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Kohji MoriishiDepartment of Microbiology, Faculty of Medicine, University of Yamanashi, Yamanashi 400-8510, Japan.
Kyoji MoriyaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan.
Yoshiharu MatsuuraDepartment of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; toru@biken.osaka-u.ac.jp matsuura@biken.osaka-u.ac.jp.
Osaka University · JPThe University of Tokyo · JPUniversity of Yamanashi · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signal peptide peptidase (SPP) is an intramembrane aspartic protease involved in the maturation of the core protein of hepatitis C virus (HCV). The processing of HCV core protein by SPP has been reported to be critical for the propagation and pathogenesis of HCV. Here we examined the inhibitory activity of inhibitors for γ-secretase, another intramembrane cleaving protease, against SPP, and our findings revealed that the dibenzoazepine-type structure in the γ-secretase inhibitors is critical for the inhibition of SPP. The spatial distribution showed that the γ-secretase inhibitor compound YO-01027 with the dibenzoazepine structure exhibits potent inhibiting activity against SPP in vitro and in vivo through the interaction of Val223 in SPP. Treatment with this SPP inhibitor suppressed the maturation of core proteins of all HCV genotypes without the emergence of drug-resistant viruses, in contrast to the treatment with direct-acting antivirals. YO-01027 also efficiently inhibited the propagation of protozoa such as

Indexed as

Amyloid Precursor Protein SecretasesAnimalsAntiprotozoal AgentsAntiviral AgentsAspartic Acid EndopeptidasesCell LineDibenzazepinesHEK293 CellsHepacivirusHumansMiceMice, Inbred BALB CModels, MolecularPlasmodium falciparumProtease InhibitorsStructure-Activity RelationshipAmyloid Precursor Protein SecretasesAntiprotozoal AgentsAntiviral AgentsAspartic Acid EndopeptidasesDibenzazepinesProtease Inhibitorssignal peptide peptidaseViral Core ProteinsHCVpathogenesispropagationProtozoaSPP

Identifiers

PMID29187532
PMCPMC5740650
OpenAlexW2772209004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.